Mikkel Pedersen, Ph.D.CSO at Symphogen
Profile
Mikkel Wandahl Pedersen, is CSO at Symphogen a Servier Company. Mikkel has 15 years of experience in antibody discovery and development and contributed to the discovery and development of seven clinical stage antibody drug candidates within oncology and immuno-oncology. Mikkel has co-authored more than 40 peer-reviewed publications.
Agenda Sessions
Advantages and Challenges of Chicken-derived Therapeutic Antibodies
On DemandView SessionAntibody Screening, Discovery and Technology
16:00View Session